New method to generate virus-like particles, to help with developing antibodies against Nipah

With the new technique developed by the Institute of Advanced Virology, it will now be possible to conduct tests crucial for the development of vaccines in biosafety level-2 labs. Now, such tests are done only in biosafety level-4 labs, because of the extreme precautions required. The newly developed particles closely resemble viruses, but are non-infectious